Codexis to Announce Second Quarter 2012 Financial Results on August 9, 2012

Codexis to Announce Second Quarter 2012 Financial Results on August 9, 2012

<0> Codexis, Inc.Investors: 212-362-1200Kelly McAlearney, 415-503-4073 (Media) </0>

Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced it will host a conference call and webcast on Thursday, August 9, 2012 at 4:30 p.m. Eastern Time to discuss its second quarter 2012 financial results for the period ended June 30, 2012. The call and webcast will follow the release of second quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, , and will be archived for up to 30 days.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals. Codexis' product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see .

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.